Anne Burke, MD
Obstetrics & Gynecology · Baltimore, MDNPI 1831157320
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,220 of the $12,273 with a category attached, or 67.0%. Therapeuticsmd, Inc. accounts for 74.8% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $8,045 and has fallen 61.5% since, to $3,095 in 2023. Among obstetrics & gynecology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 9 payments — averaging $1363.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Therapeuticsmd, Inc.$9K
- Exeltis, USA Inc.$3K
Across 49 payments — averaging $2994.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Exeltis, USA Inc.$125K
- Merck$21K
- Organon$689
What the payments were for
- Consulting fees$8,22067%
- Speaking & faculty fees$2,00416%
- Travel & lodging$1,95016%
- Food & beverage$991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Therapeuticsmd, Inc. | 8 | $9,178 |
| Exeltis, USA Inc. | 1 | $3,095 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,273 in reported general payments places this provider in the 95th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $1,892 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Baltimore
- Danielle ShillerBaltimore$221K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Christina EnzmannBaltimore$63K
- Latasha MurphyBaltimore$41K
- Ishrat RafiBaltimore$29K
- Colleen McCormickBaltimore$29K
- Jenell ColemanBaltimore$18K
- David MatthewsBaltimore$12K
- Michelle KushBaltimore$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.